The wire — 3 September 2026

Wednesday's briefing arrived without qualifying rounds because the PR machinery was still warming up. Thursday's catch-up closes that gap: three announcements from September 2 that came through after Tuesday's 07:00 cut — a German rocket maker, a Spanish pregnancy diagnostics company, and a London AI startup. No single theme connects the three; the honest description is a rentrée scatter — Europe's funding desks clearing a queue of deals completed in August and announced in the first days back.

HyImpulse (Neuenstadt am Kocher) is the headline by size: a €50M+ Series A+ extension, co-led by JOIN Capital and Ace Capital Partners, with new investors North Ventures, BW-Capital, Bayern Kapital, and the German Aerospace Center (DLR) also joining. Total equity and public funding exceeds €125 million. The DLR spinout develops hybrid-propellant rockets — paraffin and liquid oxygen — for commercial small-satellite launches: the suborbital SR75 is in active flight testing, and the orbital SL1 is targeting its maiden flight before year-end. The figure that frames the round is not the capital raised but the order book: more than €350 million in signed contracts across both programmes. The next 18 months are a pure execution test.

iPremom (Valencia) closes a €15 million seed led by Amadeus Capital Partners, with Asabys Partners and APEX Ventures participating. The company — founded by endometrial genomics pioneer Prof. Carlos Simón (previously co-founder of Igenomix) and Dr. Tamara Garrido — has developed MaiRa, a first-trimester blood test that analyses cell-free RNA signals to predict pregnancy complications including preeclampsia between weeks nine and fourteen, months before clinical symptoms appear. The platform is trained on more than 26,000 samples from around 10,000 pregnancies. The €15M goes toward EU and US regulatory validation — the gate between a promising dataset and a reimbursable clinical test.

Pharosyn (London) closes a $3 million (~€2.5M) pre-seed led by Moonfire Ventures, with Entrepreneurs First, Transpose Platform, and General Advance alongside. Founded in 2025 by Cambridge graduates Stephen Cowley and Joshua Hampson, the company builds AI-powered competitive intelligence infrastructure for biopharma commercial teams: the same strategic report that once took four hours to assemble now takes fifteen minutes. The Moonfire connection is worth noting — the fund previously backed MokN (Paris, €12.9M Series A), its first French investment, suggesting a pattern of early, Cambridge-linked technical bets across sectors.

France was again quiet on Wednesday — no qualifying French rounds reached the wire for the September 2 window. The desk continues to watch French-language sources for the week's first substantive announcements.